Polyphor Provides Update on the Phase III FORTRESS Study of Balixafortide in Patients…
Co-primary endpoint of the study objective response rate (ORR) was not metThe board of directors is undergoing a strategic assessment regarding the future of the company ALLSCHWIL,…